Kenneth S. Thomson

KPC Screening by Updated BD Phoenix and Vitek 2 Automated Systems

Kenneth S. Thomson, Iraida E. Robledo, Guillermo J. Vázquez, 2011, Journal of Clinical Microbiology.

Automated preparation for identification and antimicrobial susceptibility testing: evaluation of a research use only prototype, the BD Kiestra IdentifA/SusceptA system

James W. Snyder, Kenneth S. Thomson, Gina K. Thomson, 2020 .

Cefepime, Piperacillin-Tazobactam, and the Inoculum Effect in Tests with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

Kenneth S. Thomson, E. S. Moland, K. Thomson, 2001, Antimicrobial Agents and Chemotherapy.

Potential Impact of the VITEK 2 System and the Advanced Expert System on the Clinical Laboratory of a University-Based Hospital

Kenneth S. Thomson, M. Peyret, E. S. Moland, 2001, Journal of Clinical Microbiology.

Can Results Obtained with Commercially Available MicroScan Microdilution Panels Serve as an Indicator of β-Lactamase Production among Escherichia coli andKlebsiella Isolates with Hidden Resistance to ExpandedSpectrum Cephalosporins and Aztreonam?

Kenneth S. Thomson, E. S. Moland, K. Thomson, 1998, Journal of Clinical Microbiology.

Ability of the VITEK 2 Advanced Expert System To Identify β-Lactam Phenotypes in Isolates of Enterobacteriaceae andPseudomonas aeruginosa

Kenneth S. Thomson, M. Peyret, E. S. Moland, 2000, Journal of Clinical Microbiology.

Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase Issues

Kenneth S. Thomson, K. Thomson, Kenneth S. Thomson, 2010, Journal of Clinical Microbiology.

Comparison of Phoenix and VITEK 2 Extended-Spectrum-β-Lactamase Detection Tests for Analysis of Escherichia coli and Klebsiella Isolates with Well-Characterized β-Lactamases

Kenneth S. Thomson, Ellen S. Moland, E. S. Moland, 2007, Journal of Clinical Microbiology.